Early elevation of serum thrombopoietin levels and subsequent thrombocytosis in healthy preterm infants

British Journal of Haematology

Volumn 115, Issue 4, 2001, Pages 963-968

  Matsubara, Kousaku ^a   Baba, Kunizo ^a   Nigami, Hiroyuki ^a   Harigaya, Hidekazu ^a   Ishiguro, Akira ^b   Kato, Takashi ^c   Miyazaki, Hiroshi ^c  

^a NISHI KOBE MEDICAL CENTER   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

Author keywords

Cord blood; Interleukin 6; Preterm low birth weight infant; Reactive thrombocytosis; Thrombopoietin

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 6; THROMBOPOIETIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; KINETICS; LOW BIRTH WEIGHT; MALE; NEWBORN; NEWBORN PERIOD; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; THROMBOCYTOSIS; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; FETAL BLOOD; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTERLEUKIN-11; INTERLEUKIN-6; PLATELET COUNT; THROMBOCYTOSIS; THROMBOPOIETIN;

EID: 0035677046     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03183.x     Document Type: Article

References (36)

1. Thrombopoietin in the thrombocytopenic term and preterm newborn
2. Venous platelet counts in low birth weight infants
3. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer
4. Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat
5. Decreased response of plasma immunoreactive erythropoietin to 'available oxygen' in anemia of prematurity
6. Thrombopoietin levels in patients with primary and reactive thrombocytosis
7. Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant
8. Circulating thrombopoietin levels in neonates with infection
9. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial
10. Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels
11. Growth factors affecting human thrombocytosis: Potential agents for the treatment of thrombocytopenia
12. Effects of recombinant human erythropoietin in infants with the anemia of prematurity: A pilot study
13. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis
14. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis
15. Stressful delivery influences circulating thrombopoietin (TPO) levels in newborns: Possible role for cortisol in TPO-mpl binding
16. Interleukin-6 is a potent thrombopoietic factor in vivo in mice
17. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease
18. Age-related changes in thrombopoietin in children: Reference interval for serum thrombopoietin levels
19. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease
20. Thrombopoietin
21. Thrombopietin expands erythroid progenitors, increased red cell production, and enhances erythroid recovery after myelosupprresive therapy
22. Thrombocytosis in low birthweight infants. A physiological phenomenon in infancy
23. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection
24. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies
25. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies
26. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit
27. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development
28. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans
29. Thrombocytosis in childhood
30. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: Serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders
31. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy
32. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis
33. Measurement of thrombopoietic levels: Clinical and biological relationships
34. Secondary thrombocytosis
35. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies
36. Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis